SARAH SIMS: Open Payments
NPI 1528767910 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 42 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $310 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $161 |
| Novo Nordisk Inc | 9 | $157 |
| SANOFI-AVENTIS U.S. LLC | 4 | $85 |
| Madrigal Pharmaceuticals | 3 | $81 |
| ABBVIE INC. | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $42 |
| Boston Scientific Corporation | 1 | $30 |
| ViiV Healthcare Company | 1 | $29 |
| Astellas Pharma US Inc | 1 | $28 |
| Cochlear Americas | 1 | $24 |
Products named: PREVNAR 20, TZIELD, REZDIFFRA, Ozempic, NURTEC ODT, Wegovy, VRAYLAR, General - Pain Management.
Industry payments across GA — which companies pay providers there.
